SPIE Photonics West Digital Forum Showcases Best of Optics, Photonics, Quantum, Biomedical Technologies in Applications and Research
17.3.2021 19:08:00 EET | Business Wire | Press release
SPIE, the international society for optics and photonics, welcomed an engaged global audience to its SPIE Photonics West Digital Forum 6-11 March with 8,000 registered attendees. Across the highly regarded BiOS, LASE, and OPTO symposia, as well as the new industry-focused Quantum West conference, SPIE Photonics West showcased more than 20 plenary speakers, including Ursula Keller, Gérard Mourou, Susumu Noda, Satoshi Kako, Kohji Mitani, Sheila Nirenberg, Laura Fabris, and Yeka Aponte. More than 100 live events – including panel sessions, technical discussions, and networking events complemented the 3,200 on-demand presentations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210317005651/en/
SPIE Photonics West Digital Forum showcases best of optics, photonics, quantum, biomedical technologies in applications and research (Photo: Business Wire)
In addition, two Digital Marketplaces – one for Photonics West, one for BiOS – together showcased more than 400 exhibitors and over 100 product demonstrations of the latest innovations in optics and photonics.
The largest photonics virtual event of 2021, SPIE Photonics West spotlighted and recognized the best optics and photonics technologies, trends, and entrepreneurial innovations, offering many opportunities for attendees, presenters, scientists, and engineers to engage and discuss their latest research and work. From COVID-focused diagnostics advancements and neuro-technologies to lasers in manufacturing and data center communications, SPIE Photonics West offered a dynamic week of information sharing, learning, and conversation.
Quantum West, a new conference on quantum technology held in partnership with the QED-C, featured industry leaders such as Celia Merzbacher, Peter Knight, Andrew Lord, Wilhelm Kaenders, and Kaitlin Moore exploring the role of photonics in quantum technology’s growth from R&D into engineering products for commercial applications.
"I have worked with SPIE over many years, as both an exhibitor and conference chair, and am very happy to help build Quantum West together with them,” said Quantum West Co-Chair Tim Day who serves as DRS Daylight Solutions GM and senior VP, as well as Member of the Board of ColdQuanta. “SPIE did a great job under challenging circumstances and is always a wonderful partner in terms of bringing the community together and helping to advance photonics technology. We, along with many others in the photonics community, are looking forward to an in-person meeting next January in San Francisco.”
Other industry-focused events featured live sessions with thought leaders discussing today’s hottest application areas, including industrial lasers, sensing and imaging, and autonomous vehicles.
“I come to Photonics West every year with my students,” said Jennifer Barton, who is co-chair for BiOS as well as the director of the University of Arizona’s BIO5 Institute and the university’s Thomas R. Brown Distinguished Professor of Biomedical Engineering. “This year, three of them presented virtually, along with myself. I was very impressed with the high quality of live and prerecorded presentations, the flawless execution of events, and the surprisingly effective opportunities for networking and fun – go Trivia Night! Of course, I am looking forward to seeing everyone in person next year, but I loved how engaging and informative this conference week was.”
“Photonics West is the largest biomedical, laser, and optoelectronic event in our field, even when we cannot travel,” noted SPIE Senior Director of Technical Programs Marilyn Gorsuch. “Given the virtual circumstances, our volunteer conference chairs rolled up their sleeves and produced an amazing offering to present and discuss the latest technical advancements. But nothing can replace the in-person experience and the excitement of gathering together at Photonics West in San Francisco. We are very much looking forward to hosting Photonics West in San Francisco next January.”
All the Photonics West content will be available on the SPIE Digital Library from 20 March.
Photonics West 2022 will take place 22-27 January at the Moscone Center in San Francisco. The Call for Papers will be announced and open in the next few weeks.
About SPIE
SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves more than 258,000 constituents from 184 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2020, SPIE provided over $5 million in community support including scholarships and awards, outreach and advocacy programs, travel grants, public policy, and educational resources. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210317005651/en/
Contact information
Daneet Steffens
Public Relations Manager
daneets@spie.org
+1 360 685 5478
@SPIEtweets
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The smarter E Europe: The Special Exhibit Renewables 24/7 Shows How a Renewable Energy Supply Is Possible21.4.2026 14:00:00 EEST | Press release
The current geopolitical situation once again highlights the risks of depending on fossil fuels and the increasing need to transform our energy supply. Solar and wind power have long been established as cost-efficient energy sources, and the International Energy Agency (IEA) has predicted a global 2.6-fold capacity growth between 2022 and 2030. Against this backdrop, The smarter E Europe alliance of exhibitions will spotlight the feasibility of a renewable energy system from June 23–25 in Munich. The Special Exhibit Renewables 24/7 uses best practices, presentations and live demos to show how a round-the-clock renewable energy supply can be achieved. To kick off the exhibition on June 23, The smarter E Europe will present an exclusive accompanying study, conducted in collaboration with the Fraunhofer Institute for Solar Energy Systems, that dispels common myths about system stability and provides scientific proof that such an energy system is viable. The study, Pathways to a Renewable
The smarter E Europe: The Special Exhibit Renewables 24/7 Shows How a Renewable Energy Supply Is Possible21.4.2026 14:00:00 EEST | Press release
The current geopolitical situation once again highlights the risks of depending on fossil fuels and the increasing need to transform our energy supply. Solar and wind power have long been established as cost-efficient energy sources, and the International Energy Agency (IEA) has predicted a global 2.6-fold capacity growth between 2022 and 2030. Against this backdrop, The smarter E Europe alliance of exhibitions will spotlight the feasibility of a renewable energy system from June 23–25 in Munich. The Special Exhibit Renewables 24/7 uses best practices, presentations and live demos to show how a round-the-clock renewable energy supply can be achieved. To kick off the exhibition on June 23, The smarter E Europe will present an exclusive accompanying study, conducted in collaboration with the Fraunhofer Institute for Solar Energy Systems, that dispels common myths about system stability and provides scientific proof that such an energy system is viable. The study, Pathways to a Renewable
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments21.4.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the platform powering a nationwide network of interventional psychiatry practices. This collaboration will inform how small-to-medium sized clinics nationwide can effectively deliver novel psychedelic treatments, if FDA approved. The agreement with Osmind further expands the set of collaborations that Compass has established to inform the potential delivery of COMP360 in a broad spectrum of settings where people living with mental health conditions receive their care in the United States. Osmind is a public benefit corporation advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need. Osmind’s network of over 1,000 clinics comprises one of the country’s largest network of interventional psychiatry practices. Its
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments21.4.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the platform powering a nationwide network of interventional psychiatry practices. This collaboration will inform how small-to-medium sized clinics nationwide can effectively deliver novel psychedelic treatments, if FDA approved. The agreement with Osmind further expands the set of collaborations that Compass has established to inform the potential delivery of COMP360 in a broad spectrum of settings where people living with mental health conditions receive their care in the United States. Osmind is a public benefit corporation advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need. Osmind’s network of over 1,000 clinics comprises one of the country’s largest network of interventional psychiatry practices. Its
Aventon Expands B2B Payment Terms Program to Germany with TreviPay21.4.2026 12:00:00 EEST | Press release
TreviPay, a global B2B payments infrastructure partner, today announced the expansion of its partnership with Aventon to support the launch of the Aventon Payment Terms program in Germany. Building on the success of Aventon’s existing program in the US and Canada, the new offering will give qualified B2B buyers in Germany access to invoicing and flexible payment terms designed to make purchasing easier and more predictable. As Aventon enters the German market and expands its presence in Europe, TreviPay will serve as the exclusive provider of payment terms for Aventon’s B2B buyers. The program is designed to help Aventon’s retail partners buy more confidently and manage working capital more effectively, while supporting the brand’s long-term growth in a new geography. By offering trade credit through TreviPay, Aventon can give retailers greater purchasing flexibility and strengthen its ability to compete in a dynamic market. TreviPay research shows 78% of B2B buyers say offering invoic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
